So, How’s The Book?
“Oh, it’s getting there. Slowly but surely, and right now just a tad slower than usual…”
News
Famypra Update - June 2015
An article in the Sunday Business Post by journalist Susan Mitchell reports that a HSE representative said 'significant progress has been made in commercial discussions with Biogen' (the makers of the multiple sclerosis (MS) drug Famypra)